Sei Investments Co. Boosts Stake in Acadia Healthcare Company, Inc. $ACHC

Sei Investments Co. raised its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 39.0% during the first quarter, HoldingsChannel.com reports. The firm owned 316,398 shares of the company’s stock after buying an additional 88,841 shares during the quarter. Sei Investments Co.’s holdings in Acadia Healthcare were worth $7,401,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. EverSource Wealth Advisors LLC grew its holdings in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Federated Hermes Inc. lifted its position in Acadia Healthcare by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock valued at $623,000 after buying an additional 668 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in Acadia Healthcare by 0.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock valued at $1,063,000 after buying an additional 696 shares in the last quarter. Public Employees Retirement System of Ohio grew its stake in Acadia Healthcare by 2.8% during the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock worth $776,000 after buying an additional 867 shares during the period. Finally, Treasurer of the State of North Carolina increased its position in shares of Acadia Healthcare by 2.1% in the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock worth $964,000 after acquiring an additional 867 shares in the last quarter.

Acadia Healthcare Price Performance

ACHC opened at $29.62 on Monday. The company has a market capitalization of $2.76 billion, a P/E ratio of -2.38, a PEG ratio of 9.61 and a beta of 0.64. The company has a 50-day moving average of $28.23 and a 200-day moving average of $23.81. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. Acadia Healthcare Company, Inc. has a 1-year low of $11.43 and a 1-year high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. The business had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The company’s revenue for the quarter was down .4% compared to the same quarter last year. During the same period last year, the firm earned $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Equities analysts expect that Acadia Healthcare Company, Inc. will post 1.54 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ACHC has been the topic of several recent research reports. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their target price for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. Cantor Fitzgerald reissued a “neutral” rating on shares of Acadia Healthcare in a research report on Wednesday. Guggenheim boosted their price objective on Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday. Barclays increased their target price on Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research note on Thursday. Finally, Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price on the stock in a report on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $29.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.